A new challenge towards future growth, Daido Life will contribute to creating a society where SMEs and the employees can be healthy and active participants over the long term. This will be carried out by going beyond the conventional scope of a life insurance company to develop innovative products and services addressing “health promotion and disease prevention,” and “return to society through treatment of intractable disease.”
Initiatives to Disseminate Health and Productivity Management—DAIDO KENCO ACTION
Generally, an early dissemination of Health and Productivity Management*1 is necessary especially for SMEs where the role per employee is relatively large and face issues with health management. However, the recognition of Health and Productivity Management is low among SMEs and they also lack the human resources and the expertise in implementing it.
In light of these situations, Daido Life is taking a dual approach in the promotion of dissemination activities of Health and Productivity Management, which is working to raise awareness of the principles among SME owners through seminars and providing a concrete tool for implementation through offering of the Daido Life KENCO SUPPORT PROGRAM. (From April 2017)
- *1 Health and Productivity Management is an approach of implementing health management from a business management perspective, based on the idea that initiatives for enhancing employee health are an investment in raising the productivity of the company.
- *2 Source: Rearranged and processed from Statistics Bureau, the Ministry of Internal Affairs and Communications “2014 Economic Census for Business Frame.” Total number of companies and individual proprietors.
Launch of “HAL Plus Rider”
Daido Life launched the industry’s first “HAL plus rider” for covering treatment of certain intractable diseases with the robot suit HAL® for Medical Use (Lower Limb Type) developed and supplied by CYBERDYNE, INC. (From July 2017)
By adding this rider to Daido Life’s M-type product (non-participating comprehensive medical insurance), the product becomes even more attractive. The company will also contribute to creating a society where people are healthy and affluent by promoting the dissemination and penetration of treatment for intractable disease using HAL® for Medical Use.
[Reference]
HAL® (Hybrid Assistive Limb®) is a cyborg-type robot developed by CYBERDYNE, INC. The suit can improve, support and enhance the bodily functions. HAL® for Medical Use has obtained approval as a therapeutic device in Europe and Japan as the world’s first robotic therapeutic device.
In Japan, eight patients with intractable neuromuscular disease started treatment with the new therapeutic devices from September 2016, funded by public medical insurance.
- Medium-Term Management Plan
- Taiyo Life Insurance Company
- Daido Life Insurance Company
- T&D Financial Life Insurance Company
- T&D Asset Management Co., Ltd.
- Pet & Family Small-amount Short-term Insurance Company
- Outlook for Sales Performance IndicatorsFiscal 2017
-
- Policy amount in force*
- ¥41,780 billion
- New policy amount*
- ¥4,350 billion
- * The sum of the death benefit amount of individual insurance and individual annuities, together with the insured amount for critical illnesses for the J-type product (non-participating critical illness insurance), disability income protection for the T-type product (non-participating disability benefit), and Kaigo Relief (non-participating whole life nursing care insurance).
- Fundamental Strategy
-
- Further evolve the core business of selling partner-specific products through tie-up organizations by “further penetrating core markets” and “creating and expanding new markets.”
- Business Model
